Viewing Study NCT02254993


Ignite Creation Date: 2025-12-25 @ 1:15 AM
Ignite Modification Date: 2026-01-05 @ 3:10 AM
Study NCT ID: NCT02254993
Status: COMPLETED
Last Update Posted: 2019-08-01
First Post: 2014-09-24
Is NOT Gene Therapy: True
Has Adverse Events: False

Brief Title: Phase 2, Open-Label Study for Safety, Microbiology and PK of Single or Multiple Oral C16G2 Gel Doses
Sponsor: Armata Pharmaceuticals, Inc.
Organization:

Study Modules

Identification Module Status Module Sponsor Collaborators Module Oversight Module Description Module Conditions Module Design Module Arms Interventions Module Outcomes Module Eligibility Module Contacts Locations Module